ArticleCureus2026
Epidemiological Indicators of Tuberculosis in the Federal District, Brazil: Treatment Follow-Up and Case Closure Outcomes From 2015 to 2022.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Tuberculosis (TB) remains a relevant public health problem in Brazil, and in the Federal District it continues to pose challenges related to diagnosis, treatment adherence, and continuity of care. Monitoring epidemiological indicators is essential to identify weaknesses in TB control and to guide health system responses. Objective To analyze the epidemiological situation of TB in the Federal District, Brazil, from 2015 to 2022, focusing on patient profile, treatment monitoring, and case closure outcomes, as well as to assess the impact of the COVID-19 pandemic on TB care. Methods A descriptive epidemiological study was conducted using secondary data from the National Notifiable Diseases Information System, accessed through the Brazilian Ministry of Health database. The variables analyzed included the annual incidence of new TB cases, sociodemographic characteristics, type of case entry, directly observed treatment (DOT) coverage, and treatment outcomes. Population estimates were based on official census data. Results A marked reduction in TB case detection and treatment success indicators was observed from 2020 onward, coinciding with the COVID-19 pandemic. Decreased cure rates, increased treatment abandonment, reduced coverage of DOT, and higher re-entry after abandonment were identified in the Federal District. Although a partial recovery in incidence occurred in 2022, the indicators did not return to pre-pandemic levels. Conclusion The findings demonstrate the negative impact of the COVID-19 pandemic on TB surveillance and care in the Federal District, highlighting the need to strengthen monitoring strategies, improve treatment adherence, and reorganize health services to mitigate long-term effects on TB control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.